EUDA Health Holdings (EUDA) Return on Sales (2022 - 2023)
EUDA Health Holdings (EUDA) reported Return on Sales of 0.46% for Q2 2023, down 45.0% year-over-year from 0.83% in Q2 2022, and down 3125.1% quarter-over-quarter from 0.01% in Q1 2023.
EUDA Health Holdings (EUDA) Return on Sales (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has 2 years of Return on Sales data on file, last reported at 0.46% in Q2 2023.
- Return on Sales for Q2 2023 came in at 0.46%, down 45.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 0.03% (changed N/A YoY), and the FY2025 annual result was 0.0%, down 1.0% from the prior year.
- Return on Sales slipped to 0.46% in Q2 2023 per EUDA's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q1 2022 and troughed at 0.46% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | IHS Holding | 45.03 Bn | 44.04 Bn | 231.80 | 238.32% |
| 2 | Cbre | 38.54 Bn | 37.33 Bn | 1.85 Bn | 0.00% |
| 3 | Costar | 14.00 Bn | 12.72 Bn | 701.00 Mn | 0.00% |
| 4 | Jones Lang Lasalle | 13.85 Bn | 13.53 Bn | - | 0.00% |
| 5 | KE Holdings | 7.04 Bn | 4.80 Bn | 661.06 Mn | 0.00% |
| 6 | Compass | 5.66 Bn | 5.19 Bn | 2.31 Bn | 0.00% |
| 7 | Opendoor Technologies | 4.24 Bn | 4.17 Bn | 72.00 Mn | 0.00% |
| 8 | Cushman & Wakefield | 3.11 Bn | 2.51 Bn | 420.70 Mn | 0.00% |
| 9 | Newmark | 2.67 Bn | 2.62 Bn | - | 0.00% |
| 10 | EUDA Health Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.46% |
| Mar 31, 2023 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |